drugset / Trial / NCT01229982

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

NCT01229982

Phase 2 Completed 121 enrolled Mati Therapeutics Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test if latanoprost punctal plugs will reduce eye pressure in subjects with ocular hypertension or open-angle glaucoma.

Timeline

Start
2010-10
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule